0001104659-16-152020.txt : 20161025
0001104659-16-152020.hdr.sgml : 20161025
20161025210931
ACCESSION NUMBER: 0001104659-16-152020
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161025
FILED AS OF DATE: 20161025
DATE AS OF CHANGE: 20161025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ra Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001481512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262908274
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: SUITE B14301
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
BUSINESS PHONE: (617) 401-4060
MAIL ADDRESS:
STREET 1: ONE KENDALL SQUARE
STREET 2: SUITE B14301
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Morgenthaler Management Partners IX, LLC
CENTRAL INDEX KEY: 0001666860
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37926
FILM NUMBER: 161951361
BUSINESS ADDRESS:
STREET 1: 3200 ALPINE ROAD
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
BUSINESS PHONE: 650-388-7600
MAIL ADDRESS:
STREET 1: 3200 ALPINE ROAD
CITY: PORTOLA VALLEY
STATE: CA
ZIP: 94028
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORGENTHALER VENTURE PARTNERS IX LP
CENTRAL INDEX KEY: 0001439101
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37926
FILM NUMBER: 161951362
BUSINESS ADDRESS:
STREET 1: 2710 SAND HILL ROAD
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650-388-7600
MAIL ADDRESS:
STREET 1: 2710 SAND HILL ROAD
STREET 2: SUITE 100
CITY: MENLO PARK
STATE: CA
ZIP: 94025
3
1
a3.xml
3
X0206
3
2016-10-25
0
0001481512
Ra Pharmaceuticals, Inc.
RARX
0001439101
MORGENTHALER VENTURE PARTNERS IX LP
3200 ALPINE ROAD
PORTOLA VALLEY
CA
94028
0
0
1
0
0001666860
Morgenthaler Management Partners IX, LLC
3200 ALPINE ROAD
PORTOLA VALLEY
CA
94028
0
0
1
0
Common Stock
17142
D
Warrants to Purchase Common Stock
0.07
2022-04-01
Common Stock
63019
D
Series A Preferred Stock
Common Stock
1392130
D
Series B-1 Preferred Stock
Common Stock
523438
D
Series B-2 Preferred Stock
Common Stock
486919
D
The securities are held by Morgenthaler Venture Partners IX, L.P. ("MVP IX"). The general partner of MVP IX is Morgenthaler Management Partners IX, LLC ("MMP IX"). MMP IX may be deemed to indirectly beneficially own the securities directly held by MVP IX. MMP IX disclaims beneficial ownership of the securities held by MVP IX except to the extent of its pecuniary interest therein.
The Warrants to Purchase Common Stock have a $0.07 exercise price and are automatically exercised for shares of Common Stock on a net issuance basis upon consummation of the Issuer's initial public offering of Common Stock
Each share of the Series A Preferred Stock is convertible into Common Stock on a 1-for-7 basis automatically upon the closing of the Issuer's initial public offering, and has no expiration date.
Each share of the SeriesB-1 Preferred Stock is convertible into Common Stock on a 1-for-7 basis automatically upon the closing of the Issuer's initial public offering, and has no expiration date.
Each share of the Series B-2 Preferred Stock is convertible into Common Stock on a 1-for-7 basis automatically upon the closing of the Issuer's initial public offering, and has no expiration date.
MORGENTHALER VENTURE PARTNERS IX, L.P. By: Morgenthaler Management Partners IX, LLC, its General Partner, By: /s/ Jason Lettmann Name: Jason Lettmann, Its: Member
2016-10-25
MORGENTHALER MANAGEMENT PARTNERS IX, LLC, By: /s/ Jason Lettmann, Its: Member
2016-10-25